Back

Ivabradine is not associated with higher risk of new onset atrial fibrillation among patients with cardiac resynchronization therapy

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Arrhythmia and cardio protection pharmacotherapy Cardiovascular Pharmacotherapy, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor James Milner

ULS Entre Douro e Vouga, Santa Maria da Feira (Portugal)

5 More presentations in this session

Presentation thumbnail
Proarrhythmic pharmacotherapy and out-of-hospital cardiac arrest - A nationwide Danish study
Mr S. Kjeldsen (Gentofte, DK)
Abstract
Presentation thumbnail
Hysteresis between pharmacokinetics and changes in QRS complex duration following flecainide administered via oral inhalation or IV infusion
Ms P. Madhavapeddi (Newark, US)
Abstract Slides
Presentation thumbnail
SK channel inhibition did not increase short-term variability of the QT intervals in atrial tachypaced pigs with left ventricular dysfunction in contrast to the positive control dofetilide
Miss C. Citerni (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
AMPK/PGC1 activation by melatonin attenuates acute doxorubicin cardiotoxicity
Doctor D. Liu (Beijing, CN)
Abstract
Presentation thumbnail
Beneficial effect of landiolol on adiponectin and high-molecular weight adiponectin level in patients with stable coronary artery disease performed percutaneous coronary intervention
Assistant Professor M. Kiyokuni (Yokohama, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Arrhythmia and cardio protection pharmacotherapy

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources